Status:
UNKNOWN
Shocking Therapy for Chronic Pelvic Pain Syndrome
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Chronic prostatitis/chronic pelvic pain syndrome is an extremely common urologic diagnosis and accounts for approximately 2 million outpatient visits to urology practices in the United States alone. U...
Eligibility Criteria
Inclusion
- Exhibit symptoms of pain typical for prostatitis/CPPS
- Have had the symptoms for at least 3 months
- Have no evidence of infection in the urine or expressed prostatic secretions (the seminal plasma may be substituted if expressed prostatic secretions are not available).
- Have failed at least one therapy for CPPS
Exclusion
- Suspected or confirmed to have prostate cancer
- Have a coagulation disorders
- Use anticoagulants
- Have thrombosis
- Have used cortisone therapy up to 6 weeks before first treatment
- Are actively trying to conceive
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01828996
Start Date
February 1 2013
End Date
December 1 2019
Last Update
March 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5